Meds Update Resource Page

medicinesMedication Update Webinar

Feeling overwhelmed by all the new recently approved diabetes medications? Two bio-similiar insulins are now available and another GLP-1 RA was just approved. Plus, 2 new combo oral meds are now available.

Are you wondering how to apply the new 2018 ADA and AACE Medication Management Guidelines into practice?

We are here to help out!

This webinar discussrd how to integrate these new medications into our practice. We will discuss the benefits and limitations and critical information to share with our patients and providers.

If you want cutting edge information on the latest pharmacology we highly recommend this Meds Update.

To Join Us and earn CEs you have 2 options: 



Or Purchase our Meds Update Toolkit

Earn 3.5 CE’s – 2 Courses for Only $49

This toolkit includes:

  • Meds Update Course 2018 – cutting edge information on the latest pharmacology and how to incorporate the new ADA Guidelines into practice.
  • Basal-bolus Insulin in the Hospital Setting Course – A comprehensive program which explores the effective use of basal bolus insulin in the hospital setting through case studies and examples.

If you want cutting edge information on the latest pharmacology and hospital glucose management, we highly recommend this Meds Update Toolkit.


 New Updated Medication PocketCard

Download our CDE Coach App for free pocketcard updates

  Articles on Diabetes Medications

Pharmacologic Approaches to Glycemic Treatment 2018.  This hyperglycemia road map details strategies to achieve glucose control for both Type 1 and Type 2 Diabetes. Section 8 of Standards of Care, Dec 2018.

AACE Comprehensive Diabetes Management Algorithm 2017. A slide set summary of the ACE/AACE Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus.  Encourage all those planning to take CDE® exam to review this info carefully.

AACE – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2017 A comprehensive care plan for people with diabetes, published by the American Association of Clinical Endocrinologists and American College of Endocrinology

AADE – White Paper on Continuous Subcutaneous Insulin Therapy » This paper outlines the topics that should be covered by diabetes educators when teaching patients and families or significant others about insulin pump therapy.
Diabetes Meds on a Budget – 2017 » This article by Beverly Thomassian, provides practical and affordable strategies to manage hyperglycemia when funds are limited.
AADE – Strategies for InsulinTherapy 2011.PDF » An excellent review of the latest research on proper insulin administration techniques, patient barriers and insulin therapy.

Beyond Metformin: Safety Considerations in the Decision Making Process for Selecting a Second Medication for Type 2 Diabetes Management » This expert opinion article outlines the latest data on the safety and other considerations for currently available medications to treat type 2 diabetes. Published in Diabetes Care, 2014

Consumer Report’s Best Buy Drugs » it offers a fresh look at diabetes medication from a consumer perspective.Diabetes treatment: Insulin and incretins – Fowler, M. (2010). Clinical Diabetes – An excellent review of the latest in insulin therapy.

Novel Agents for the Treatment of Type 2 – 2014 – Diabetes Spectrum » Recent innovative treatment approaches target the multiple pathophysiological defects present in type 2 diabetes. Optimal management should include early initiation of combination therapy using multiple drugs with different mechanisms of action. This review examines novel therapeutic options that hold particular promise.
Metformin and B12 Deficiency » This complication affects about 30% of patients with diabetes who take metformin. Despite its common occurrence, vitamin B12 deficiency is often unrecognized and untreated. For this reason, patients on metformin should have their B12 level monitored annually. Published in BMJ. 2010;340:c2198
Origin Trial – NEJM 2012 – Outcome Reduction with an Initial Glargine Intervention » This large randomized prospective trial followed patients with prediabetes and diabetes who were on daily doses of basal insulin for 6 years. The study demonstrated that Lantus therapy had a neutral effect on cardiovascular outcomes and cancers.  And it reduced new onset diabetes in those with prediabetes.

Medications for Neuropathy

Painful Diabetic Neuropathy » scientific article that includes the latest research and medications that improve neuropathic pain. Also includes a step wise approach and dosing strategies for the different types of medications. Authored by Dr. Ziegler, Diabetes Care, 2009 32 (Supp 2).

Neuropathy Medications Summary Sheet » this “at a glance” summary page is designed to be a helpful tool to evaluate therapeutic improvements for your patients with diabetes neuropathy.  Authored by Beverly Thomassian.